Popular peptide combinations

BPC-157 + KPV + GHK-Cu Gut Healing Stack

Peptides in this combination: BPC-157, KPV, GHK-Cu

Triple-action gut healing: BPC-157 repairs mucosal lining, KPV inhibits NF-kB inflammation, GHK-Cu modulates anti-inflammatory gene expression.

Reported benefits: IBD/IBS symptom reduction, gut barrier restoration, leaky gut repair, mucosal healing.

Typical protocol

BPC-157: 250-500 mcg oral daily (arginate salt preferred). KPV: 500 mcg oral daily. GHK-Cu: 1 mg subQ 3x weekly. Duration: 8-16 weeks.

BPC-157 + TB-500

Peptides in this combination: BPC-157, TB-500

Tissue repair, recovery, anti-inflammatory

CJC-1295 + Ipamorelin

Peptides in this combination: CJC-1295, Ipamorelin

Growth hormone release, muscle growth

Epitalon + Thymalin Anti-Aging Bioregulator Stack

Peptides in this combination: Epitalon, Thymalin

Classic Khavinson anti-aging stack: Epitalon extends telomeres and restores circadian function; Thymalin reconstitutes age-depleted T-cell immunity.

Reported benefits: Telomere extension, circadian normalization, T-cell immune restoration, anti-aging, longevity.

Typical protocol

Epitalon: 10 mg daily subQ or IV for 10-20 days. Thymalin: 10 mg daily IM for 10 days. Two courses per year (spring and autumn).

GHK-Cu + BPC-157

Peptides in this combination: GHK-Cu, BPC-157

Skin rejuvenation, wound healing

GLOW (GHK-Cu + BPC-157 + TB-500)

Peptides in this combination: GHK-Cu, BPC-157, TB-500

Trending fixed-ratio blend for skin rejuvenation and tissue recovery (research use only; not FDA-approved).

Reported benefits: Marketed for skin firmness/tone (GHK-Cu) plus soft-tissue and tendon recovery (BPC-157, TB-500). No human trials of the blend.

Retatrutide Weight Loss Reference (Phase 3)

Peptides in this combination: Retatrutide

Phase 3 TRIUMPH-1 (May 2026): 25% weight loss at 80 weeks, 30.3% in severe obesity at 104 weeks. Triple GIP/GLP-1/glucagon agonism. Not yet FDA-approved.

Reported benefits: ~25% body-weight reduction at 80 weeks (12 mg); bariatric-equivalent outcomes at 104 weeks in severe obesity; LDL-C -20%.

Typical protocol

TRIUMPH-1 Phase 3 protocol: 2 mg weekly x4, then 4 mg, 9 mg, 12 mg escalating every 4 weeks. Investigational -- clinical trials only.

Semaglutide + CJC-1295

Peptides in this combination: Semaglutide, CJC-1295

Weight loss, metabolic optimization

Semax + Selank

Peptides in this combination: Semax, Selank

Cognitive enhancement, anxiety reduction

SS-31 + MOTS-c Mitochondrial Stack

Peptides in this combination: SS-31, MOTS-c

Dual mitochondrial optimization: SS-31 stabilizes cardiolipin and reduces ROS; MOTS-c activates AMPK and metabolic homeostasis.

Reported benefits: Mitochondrial function restoration, ROS reduction, AMPK activation, energy metabolism, longevity.

Typical protocol

SS-31: 0.1 mg/kg daily subQ. MOTS-c: 5-10 mg 3x weekly subQ. Duration: 8-12 weeks. Experimental -- very limited human data.

Thymosin Alpha-1 + BPC-157 Immune-Recovery Stack

Peptides in this combination: Thymosin Alpha-1, BPC-157

Combines immune system restoration with tissue repair. Used in post-illness recovery, long-COVID, and post-cancer rehabilitation.

Reported benefits: Immune reconstitution, Th1 enhancement, tissue repair, anti-inflammatory, recovery acceleration.

Typical protocol

Thymosin Alpha-1: 1.6 mg subQ 2x weekly. BPC-157: 250-500 mcg daily subQ or oral. Duration: 8-12 weeks.